home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

901 rows where filing_year = 2012 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, is_termination, received_date (date)

filing_period 4

  • second_quarter 244
  • first_quarter 232
  • third_quarter 214
  • fourth_quarter 211

issue_code 1

  • PHA · 901 ✖

filing_year 1

  • 2012 · 901 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1222689 UNIVERSITY OF IOWA 8b9cb3b0-199e-49de-a24f-ac185760a0b2 Q1 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 first_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2012-04-02T10:31:37.897000-04:00
1223235 SHELTER ROCK STRATEGIES, LLC 044ff090-63c8-44fd-9081-604de09fed62 Q1 SHELTER ROCK STRATEGIES, LLC 400772326 NEW YORK MEDICAL COLLEGE 2012 first_quarter PHA BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aid the client's proposal. HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2012-04-03T15:00:32.147000-04:00
1223524 JONES PUBLIC AFFAIRS, INC. d76e8fa1-cc7f-424d-b48f-1373ac9613b4 Q1 JONES PUBLIC AFFAIRS, INC. 400738211 THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES) 2012 first_quarter PHA Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-05T09:21:50.120000-04:00
1223887 INDEPENDENT PHARMACY COOPERATIVE 53525802-ccf5-4bd7-873a-076533ddf8f2 Q1 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2012 first_quarter PHA CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 1002 SAFE DOSES ACT of 2011. All provisions. Potential prescription drug track-and-trace legislation. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2012-04-06T13:35:10.240000-04:00
1223965 CYBER SECURITY RESEARCH CONSULTANTS, LLC 554643a1-e661-4595-8d7d-a1f1bf1d2e22 Q1 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2012 first_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Monitoring Protect IP Act, Monitoring SOPA Monitoring FDA Reauthorization Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-08T16:50:43.043000-04:00
1224486 VENABLE LLP 0bca596b-8999-4965-bbd8-41bcf1f0b1c9 Q1 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2012 first_quarter PHA General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act.) The Life Sciences Investment Act (S. 1410; H.R. 2632) HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-10T13:20:40.280000-04:00
1224774 INJURED WORKERS PHARMACY 446d8bf4-d5e6-4f5f-87af-fe6040645c83 Q1 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2012 first_quarter PHA Transparency of Pharmacy Benefit Mangers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshore and Harbor Workers Amendement Act of 2011 sponsored by Senator Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-11T09:13:05.413000-04:00
1224830 R.G. FLIPPO AND ASSOCIATES, INC dfe65896-6be5-4a3e-b253-c5830193a4a5 Q1 R.G. FLIPPO AND ASSOCIATES, INC 14861 ALABAMA NURSING HOME ASSOCIATION 2012 first_quarter PHA S. 1560 Nursing Homes Resident Pain Relief Act-all provisions HOUSE OF REPRESENTATIVES,SENATE 18000   0 0 2012-04-11T10:08:30.047000-04:00
1224908 RED+BLUE STRATEGIES b3de1807-63b0-4f7f-9043-86e05ccb5555 Q1 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2012 first_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Issues related to the practice of giving coupons for certain prescription medications. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-11T11:20:09.567000-04:00
1224928 AMERICAN COLLEGE OF CLINICAL PHARMACY 64b5a2ef-9c82-476d-a6a4-944a186f598f Q1 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 first_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-04-11T11:31:16.407000-04:00
1225078 PARRY, ROMANI, DECONCINI & SYMMS 6ccf28a6-af12-44f0-816f-a43df84b26f1 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T14:35:38.287000-04:00
1225087 PARRY, ROMANI, DECONCINI & SYMMS 49e4e169-62c5-4c82-85b4-f76ce34d1f62 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2012-04-11T14:47:43.123000-04:00
1225108 PARRY, ROMANI, DECONCINI & SYMMS 05fb58da-d0d3-402d-bc76-db5c4d9fab98 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T15:11:54.920000-04:00
1225141 PARRY, ROMANI, DECONCINI & SYMMS 9b0d85c7-824e-42d4-8368-023a48f021d7 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Regulatory issues involving compounded 17P and compounded Avastin. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T15:40:17.113000-04:00
1225149 PARRY, ROMANI, DECONCINI & SYMMS d7ddb76b-e396-4a4b-9476-e413f0eb9bf0 Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 first_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Regulatory issues involving compounded 17P. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-04-11T15:52:23.123000-04:00
1225192 RED+BLUE STRATEGIES f1addf39-bef3-4e58-9e66-ae4e58f2fbf0 Q1 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2012 first_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-11T16:29:49.920000-04:00
1225329 AMERICAN HEART ASSOCIATION 134face3-6ebe-45c9-bfa0-8caf36f27178 Q1 AMERICAN HEART ASSOCIATION 2525 AMERICAN HEART ASSOCIATION 2012 first_quarter PHA The Role of Cardiovascular Assessment in the Preapproval and Postapproval Settings for Drugs and Biologics Developed for the Treatment of Obesity (FDA-2012-N-0001) Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Environmental Protection Agency (EPA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Treasury, Dept of   175818 0 0 2012-04-12T08:58:04.580000-04:00
1225537 PARRY, ROMANI, DECONCINI & SYMMS 3f87d9d3-5e14-4f65-96c2-97902bf50b9c Q1 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2012 first_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2012-04-12T12:04:20.937000-04:00
1225784 DUTKO WORLDWIDE, LLC 2a9afa7b-71a9-4de0-b283-0f11aaa50b7f Q1 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2012 first_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-12T15:15:41.083000-04:00
1225855 CAPITOL HILL CONSULTING GROUP 7d554e61-3689-4511-82df-e90df26a7a08 Q1 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2012 first_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) HOUSE OF REPRESENTATIVES,SENATE 32000   0 0 2012-04-12T15:39:04.043000-04:00
1226036 BLUECROSS BLUESHIELD OF TENNESSEE 60b859f6-5f41-46cf-9e67-75c9148df8b1 Q1 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2012 first_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2012-04-13T09:50:08.230000-04:00
1226069 DENNY MILLER ASSOCIATES e3b9698f-b159-4923-bdeb-9e5aa7d1fb0c Q1 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 first_quarter PHA Prescription Drug User Fee Act Reauthorization (no number), provisions relating to approval of new drugs. H.R. 4132 - Faster Access to Specialized Treatments Act, all sections; S. 2113 Transforming the Regulator Environment to Accelerate Access to Treatments, all sections. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-13T10:03:25.597000-04:00
1226783 EVERTZ GROUP LLC e3aa2c0a-3931-459e-8d30-8ada4735818b Q1 EVERTZ GROUP LLC 400497446 MYLAN INC. 2012 first_quarter PHA Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) 30000   0 0 2012-04-13T15:50:39.170000-04:00
1226822 ACADEMY OF MANAGED CARE PHARMACY 5fd35b50-d60f-48f6-ab39-af48131b6a67 Q1 ACADEMY OF MANAGED CARE PHARMACY 48793 ACADEMY OF MANAGED CARE PHARMACY 2012 first_quarter PHA S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufaturer agrees to delay entry into the market in exhange for compensation from the manufacturer of the innovator product HR 1483 & HR 3988 - would introduce reforms and reauthorizations of the FDA, including the prescription drug user fee act S 296 and HR 2245 - legislation that would address shortages of prescription drugs HR 2746 - legislation that would require cost-sharing parity between all cancer medications within pharmacy benefits regulated under ERISA HR 979 - legislation that would implement transparency standards and other regulations for pharmacy benefit managers working within the Federal Employees Health Benefits Program HR 4209 - legislation that would require group and individual health insurance policies covered under ERISA and which use a formulary for prescription drug coverage to charge the same co-payment/co-insurance rate for specialty drugs as the co-payment/co-insurance rate for non-preferred brand drugs HR 1971 and S 1058 - legislation that would impose transparency and audit requirements for PBMs contracting with group health plans. HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2012-04-13T16:13:03.630000-04:00
1226954 RED+BLUE STRATEGIES 9849f021-57cd-40b7-9592-7c8230d0d52d Q1 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2012 first_quarter PHA H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Related issues being considered in pending User Fee Reauthorization legislation. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-13T17:25:17.583000-04:00
1227328 THE OB-C GROUP, LLC 9994448a-354c-4b0e-bf28-178e32c09f7a Q1 THE OB-C GROUP, LLC 29802 ELI LILLY 2012 first_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-16T10:06:35.680000-04:00
1227341 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) e0a50bc2-8b90-43fc-83d9-ef0ee01d588f Q1 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2012 first_quarter PHA Importation of Presceiption Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/draft PDUFA legislation); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245/H.R. 3839/draft PDUFA legislation); Cargo/Product Theft (S. 1002/H.R. 4223); Import Safety (S. 1584); Counterfeit Drugs (S. 1886/H.R. 3668); Internet Pharmacy (S. 2002/H.R. 4095) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   282000 0 0 2012-04-16T10:11:43.433000-04:00
1227405 FORGE FEDERAL AFFAIRS LLC d59d6016-24e1-40f2-b475-ec90c7fa7d9d Q1 FORGE FEDERAL AFFAIRS LLC 400865535 LILLY USA LLC 2012 first_quarter PHA Issues related to Prescription Drug User Fee Act (PDUFA).       0 0 2012-04-16T10:36:19.317000-04:00
1227536 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 807c9acc-a16b-4694-a66d-0aa5aa56a9d9 Q1 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 26672 NATIONAL ASSOCIATION OF CHAIN DRUG STORES 2012 first_quarter PHA S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011 S.2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE   560000 0 0 2012-04-16T11:08:27.217000-04:00
1227647 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5d875db2-0dbc-4fd8-8fdc-a515379e54cf Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 first_quarter PHA Issues related to anti-epileptic drugs. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2012-04-16T11:42:16.477000-04:00
1227697 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS ea38054c-44e7-4af1-bb02-1798b25685b5 Q1 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2012 first_quarter PHA the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Prescription Drug User Fee Act (PDUFA) reauthorization legislation Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   27325 0 0 2012-04-16T12:05:42.737000-04:00
1227800 THORN RUN PARTNERS 2cfbbfeb-5d76-44c5-8711-ed272948ca44 Q1 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2012 first_quarter PHA S.1560, Nursing Home Resident Pain Relief Act of 2011; Issues related to the implementation of the Affordable Care Act (ACA, DEA enforcement of controlled substances in nursing homes and the practice of consultant pharmacy. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-16T12:44:31.640000-04:00
1227907 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c9cc548e-2c69-4add-a243-572b710386e6 1A CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 first_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE     0 0 2012-04-16T13:14:23.227000-04:00
1228054 POLICY DIRECTIONS INC. d15fcfc3-43cc-46c1-8a50-617eaa83fe5b Q1 POLICY DIRECTIONS INC. 31747 ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) 2012 first_quarter PHA Antibiotics in animal foods Drug approvals Drugs in animal foods Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-16T14:10:24.797000-04:00
1228142 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9a7a8e56-ebd8-4684-a4aa-bd7cbb3f232b Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2012 first_quarter PHA Issues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-04-16T14:42:57.043000-04:00
1228154 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7f9f0a66-6fe6-45f8-8e55-03b3ea30421c Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 first_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2012-04-16T14:48:02.390000-04:00
1228251 MCKENNA, LONG & ALDRIDGE 8bc1055f-a5e0-4993-b03d-2c6e42f429a3 Q1 MCKENNA, LONG & ALDRIDGE 76913 REVANCE THERAPEUTICS, INC. 2012 first_quarter PHA Any issues impacting biopharmaceutical companies       0 0 2012-04-16T15:21:42.243000-04:00
1228296 NOVO NORDISK INC. e5e79b3e-bfbf-4aa3-87c3-6e8278709e72 Q1 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2012 first_quarter PHA P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,White House Office   670000 0 0 2012-04-16T15:37:04.017000-04:00
1228319 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 10b6347b-c0d0-42a1-96a5-1656f01c1fc9 Q1 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 first_quarter PHA Issues related to drug shortages. S.296/HR2245 Preserving Access to Life Saving Medications Act, HR3839 Drug Shortage Prevention Act Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-04-16T15:44:13.423000-04:00
1229465 THE INGRAM GROUP LLC 590253d5-05e1-4668-99a9-5ec0de1244fe Q1 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 first_quarter PHA Issues related to pharmaceutical importation. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-17T13:30:00.397000-04:00
1229859 STEVE BUYER GROUP b2d28ab3-5c5f-4fdc-bf11-f736544d250e Q1 STEVE BUYER GROUP 400701097 OMNICARE 2012 first_quarter PHA Advocacy in support of S 1560 promoting changes to the Controlled Substance Act providing access to pain medication for nursing. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-17T15:46:40.827000-04:00
1229871 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 1e80caf3-aa4c-4ddd-8e63-501588381f21 Q1 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 TEVA PHARMACUETICALS USA 2012 first_quarter PHA Issues affecting user fee act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T15:48:46.983000-04:00
1229983 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC bc24bacd-7041-4843-96a1-f2d34c0d437c Q1 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 WOCKHARDT USA LLC 2012 first_quarter PHA Preemption issues under the FDA Act; user fee issues HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-17T16:12:33.850000-04:00
1230213 GREATER NEW YORK HOSPITAL ASSOCIATION 2c7aae11-6038-4111-a769-016093703757 Q1 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2012 first_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   220000 0 0 2012-04-17T17:06:13.713000-04:00
1230787 SQUIRE PATTON BOGGS 42c605eb-61ad-4af5-adfe-dd2e94f1862d Q1 SQUIRE PATTON BOGGS 30906 KV PHARMACEUTICAL COMPANY 2012 first_quarter PHA Issues regarding Medicaid coverage of Makena and regulatory treatment of Makena. HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2012-04-18T06:46:55.877000-04:00
1230835 SQUIRE PATTON BOGGS 68a033f1-5b98-445a-8cf2-6b162d4520ef Q1 SQUIRE PATTON BOGGS 30906 RANBAXY INC. 2012 first_quarter PHA S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; H.R. 3630, the Middle Class Tax Relief and Job Creation Act; Prescription Drug User Fee Reauthorization issues. HOUSE OF REPRESENTATIVES,SENATE 180000   0 0 2012-04-18T07:11:21.493000-04:00
1230920 EISAI INC. 84b13d4a-8786-4369-99f8-e8f3a328ee50 Q1 EISAI INC. 400321512 EISAI INC. 2012 first_quarter PHA drug shortages, supply chain integrity DEA-FDA issues Prescription Drug User Fee Act reauthorization HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of   930000 0 0 2012-04-18T08:28:52.830000-04:00
1230933 CASSIDY & ASSOCIATES, INC. c02d2e74-8f2a-43f6-aa45-8285a07f8a90 Q1 CASSIDY & ASSOCIATES, INC. 8453 ADAMIS PHARMACEUTICALS CORPORATION 2012 first_quarter PHA regualtory relief with FDA HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-18T08:44:57.390000-04:00
1231257 ARTEMIS STRATEGIES 3a7558d2-d92f-4f15-b243-3c9fc9243185 1T ARTEMIS STRATEGIES 82990 SCRIPS AMERICA 2012 first_quarter PHA FDA approval of DESI drugs HOUSE OF REPRESENTATIVES,SENATE 50000   0 1 2012-04-18T10:34:07-04:00
1231329 UPS (UNITED PARCEL SERVICE) 9b5edd61-2c14-4aac-bfe0-3046572e20a3 Q1 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2012 first_quarter PHA - S.1584/HR 3026 "Safeguarding Americas Pharmaceuticals Act of 2011"; all issues relating to 3rd party logistics - Supply Chain Safety (Serialization v. Pedigree) Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   1476280 0 0 2012-04-18T10:52:39.653000-04:00
1231384 NATIONAL RURAL HEALTH ASSOCATION 964a5b20-f679-4ebf-a210-5efee6199e1e Q1 NATIONAL RURAL HEALTH ASSOCATION 53048 NATIONAL RURAL HEALTH ASSOCATION 2012 first_quarter PHA Support for 340B drug program. Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   171771 0 0 2012-04-18T11:05:01.800000-04:00
1231400 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 6a288383-cd6a-4b8d-8940-6cb87bf8b109 Q1 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2012 first_quarter PHA HR 2245, S 296 Supportive of language increasing access to life saving medications. HOUSE OF REPRESENTATIVES,SENATE   10734 0 0 2012-04-18T11:07:07.473000-04:00
1231508 PD FRAZER CONSULTING, INC. 31064a87-ace7-41e2-8a66-c47d35e7d3e6 Q1 PD FRAZER CONSULTING, INC. 65998 CANADA INTERNATIONAL PHARMACY ASSOCIATION 2012 first_quarter PHA Monitor the development of proposed bills about the importation of prescription drugs. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-18T11:22:54.713000-04:00
1231679 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 668ea93f-0b6b-420d-881b-cf81a1b531ea Q1 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 ALLIED MEDICAL SUPPLY, INC. 2012 first_quarter PHA Issues affecting resellers of pharmaceutical products HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-18T11:46:09.113000-04:00
1231884 FAEGRE BAKER DANIELS CONSULTING fc2537db-2824-450c-ad5a-d10901b8a0c9 Q1 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2012 first_quarter PHA On-line Pharmacies Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-18T12:11:41.310000-04:00
1232028 MARSHFIELD CLINIC HEALTH SYSTEM bd24e3ca-f214-478c-98cb-08fad39c688f Q1 MARSHFIELD CLINIC HEALTH SYSTEM 57830 MARSHFIELD CLINIC HEALTH SYSTEM 2012 first_quarter PHA Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE   130000 0 0 2012-04-18T12:40:39.350000-04:00
1232202 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 67d3be70-4d0d-4f62-b330-914bd4b92713 Q1 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 400337570 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 2012 first_quarter PHA Online Pharmacy Act and other issues impacting pharmacies and the legitimate practice of pharmacy Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   25073 0 0 2012-04-18T13:18:51.787000-04:00
1232496 WHITMER & WORRALL, LLC 670fe07e-7e49-474f-8020-c550f9689f14 Q1 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 first_quarter PHA Issues related to monitoring healthcare reform. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-18T14:03:06.317000-04:00
1233123 WINSTON & STRAWN LLP aeac9b23-00f5-4b7c-a3f7-88dedfa5995e Q1 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2012 first_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. Legislation of interest includes the America Invents Act of 2011 (H.R. 1249). HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-04-18T15:13:43.487000-04:00
1233381 AMERICAN ADVERTISING FEDERATION 04892c29-2f32-4cc0-ac9a-811a91769a63 Q1 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2012 first_quarter PHA Oppose proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Oppose proposals to require a moratorium on the advertising of new prescription medicines Oppose proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs - oppose H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health - oppos Oppose proposals to add overly-burdensome product warnings to DTC advertising Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   20000 0 0 2012-04-18T15:43:29.493000-04:00
1233730 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 9abbb687-133a-49b6-8dce-7da99d9263d5 Q1 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2012 first_quarter PHA H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2012-04-18T16:44:12.250000-04:00
1233791 POWERS PYLES SUTTER & VERVILLE, P.C. 6661c533-d4bd-47e2-8657-59ad713dc640 Q1 POWERS PYLES SUTTER & VERVILLE, P.C. 32008 340B HEALTH 2012 first_quarter PHA Section 340B of the Public Health Service Act, Section 1927 of the Social Security Act and issues related to (1) administration of the 340B Drug Discount Program, (2) implementation of 340B-related provisions in the Patient Protection and Affordable Care Act of 2010, (3) funding of the Health Resources and Services Administration (HRSA) under the FY2012 Labor Health & Human Services & Education appropriations bills, and (4) enactment of the 340B Program Improvement Act of 2011 (H.R. 2674). Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 45000   0 0 2012-04-18T16:59:54.833000-04:00
1233862 BROWN RUDNICK LLP f08f6b71-fe6e-4ddd-847d-dd5c898c7b4c Q1 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2012 first_quarter PHA Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-18T17:20:33.983000-04:00
1233872 BROWN RUDNICK LLP e58d263b-2bf5-42b4-99f4-3e0349261f10 1A BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2012 first_quarter PHA Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-18T17:21:36.527000-04:00
1233937 GENENTECH, INC 185f03dc-bfca-499f-9554-258a9a6dce5c Q1 GENENTECH, INC 15920 GENENTECH INC 2012 first_quarter PHA Monitor Drug Safety and legislation; Advocacy related to ensuring access to necessary medicines HOUSE OF REPRESENTATIVES,SENATE   1137780 0 0 2012-04-18T17:39:10.797000-04:00
1234164 RICCHETTI INCORPORATED 3a67d34c-b8d6-4fd4-aab4-29919f67c97c Q1 RICCHETTI INCORPORATED 62778 ELI LILLY AND COMPANY 2012 first_quarter PHA Issues related to pediatric exclusivity policy HOUSE OF REPRESENTATIVES,SENATE 15000   0 0 2012-04-18T19:45:30.753000-04:00
1234283 HEARTLAND SOLUTIONS GROUP, INC. a1e68986-5164-4b29-b518-66d40d270b97 Q1 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2012 first_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. HOUSE OF REPRESENTATIVES,SENATE 41250   0 0 2012-04-18T22:18:18.103000-04:00
1234506 FLYNN & ASSOCIATES, INC. 350db48e-2ca4-4b2f-83c6-fa82a147d0cd Q1 FLYNN & ASSOCIATES, INC. 15020 PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION 2012 first_quarter PHA FDA Reauthorization Pharmaceutical Industry Employment Issue HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-19T07:33:45.623000-04:00
1235163 AMERICAN VETERINARY MEDICAL ASSOCIATION de6d95ae-4a2a-46cc-9276-87c0352213f5 Q1 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2012 first_quarter PHA H.R. 965/S. 1211, Preservation of Antibiotics for Medical Treatment Act H.R. 1406, Fairness to Pet Owners Act ADUFA and AGDUFA Reauthorization Agriculture, Dept of (USDA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2012-04-19T10:18:09.467000-04:00
1235652 MCDERMOTT WILL & SCHULTE LLP 698dbff6-ae9f-41e2-a5c2-8e57e34c946e Q1 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2012 first_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-19T11:05:44.267000-04:00
1235881 THE DUBERSTEIN GROUP INC. 487e89f2-9199-44ed-a22a-54e1a27b1eff Q1 THE DUBERSTEIN GROUP INC. 12675 PFIZER INC. 2012 first_quarter PHA Addressing drug shortages, including enhanced evaluation of companies and manufacturing sites, real-cause analysis, inventory at companies, improving quality control processes - Proposed legislation re these issues. Opiate abuse issues - Proposed legislation re this issue. Tracking and tracing medicines - Proposed legislation re this issue. Antidote for exposure to chemical agents - Executive Branch action re this issue. HOUSE OF REPRESENTATIVES,SENATE 100000   0 0 2012-04-19T11:25:22.897000-04:00
1236075 STRATEGIES 360 ef16d67a-6c4d-4f48-ac9e-1fc519db75b8 Q1 STRATEGIES 360 79175 MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES 2012 first_quarter PHA Drug Utilization Review Program, Competitive bidding, HR 5597: Medicare Patient IVIG Access Demonstration Project, Medical Loss Ratio, Performance-Based Pharmacy Reimbursement, PDUFA & Biosimilars, Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-19T11:42:39.413000-04:00
1236654 CAPITOLOGIC LLC d252a314-ff5a-45e7-aca1-e5610e5e21ab Q1 CAPITOLOGIC LLC 400426045 BULALAW, LLC 2012 first_quarter PHA Federal funding of illegal prescription drug market interventions Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute of Justice,Office of Justice Program,SENATE 10000   0 0 2012-04-19T12:41:43.837000-04:00
1237032 RUBICON ADVISORS, LLC 4264d058-d8ae-49e7-bc7f-962b9724aeb4 Q1 RUBICON ADVISORS, LLC 315091 WATSON PHARMACEUTICALS INC 2012 first_quarter PHA Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 HOUSE OF REPRESENTATIVES,SENATE 98000   0 0 2012-04-19T13:19:15.850000-04:00
1237060 RUBICON ADVISORS, LLC 19d7edb7-89a8-48f1-867a-b84f73d3abda Q1 RUBICON ADVISORS, LLC 315091 TEVA PHARMACEUTICALS USA 2012 first_quarter PHA Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act HOUSE OF REPRESENTATIVES,SENATE 105000   0 0 2012-04-19T13:21:28.227000-04:00
1237075 RUBICON ADVISORS, LLC dc7233b6-825d-4647-a996-c3b04994b223 Q1 RUBICON ADVISORS, LLC 315091 GILEAD SCIENCES 2012 first_quarter PHA H.R. 822, H.R. 1943, H.R. 6114, S-2969 HOUSE OF REPRESENTATIVES,SENATE 75000   0 0 2012-04-19T13:24:36.307000-04:00
1237279 MCDERMOTT WILL & SCHULTE LLP 9ad3d6b9-19f5-4375-ade9-f599daf88595 Q1 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2012 first_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 130000   0 0 2012-04-19T13:47:03.500000-04:00
1237301 RUBICON ADVISORS, LLC f74fab88-5d56-4a72-94d1-f5bab4789bcb Q1 RUBICON ADVISORS, LLC 315091 BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. 2012 first_quarter PHA Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-19T13:50:15.860000-04:00
1237500 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 6edc489f-0cc2-45d0-837d-1551d74674cb Q1 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 29403 CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 2012 first_quarter PHA Pseudoephedrine Pseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   210000 0 0 2012-04-19T14:10:39.883000-04:00
1237782 PODESTA GROUP, INC. 937fcabc-20d9-4259-86b2-f0eda94d4225 Q1 PODESTA GROUP, INC. 31680 EISAI INC. 2012 first_quarter PHA Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-19T14:30:32.033000-04:00
1237828 APOTEX CORP. 336b2f2c-6d37-4b25-a45f-c3eec456e232 Q1 APOTEX CORP. 310973 APOTEX CORP. 2012 first_quarter PHA S. 1882, the FAIR Generics Act S. 27, the Preserve Access to Affordable Pharmaceuticals Act HR 3995, the Protecting Consumer Access to Generic Drugs Act S. 296, HR 2245, The Preserving Access to Life Savings Medications Act HR 4332, the Generic Drug Application Review Fairness Act HR 3998, Generic Drug and Biosimilar User Fee Act HR 2182, S. 1734, the Generating Antibiotic Incentives Now Act Amending Section 505(j) of the Food, Drug, and Cosmetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclaims seeking the correction of incorrect information submitted to FDA's Orange Book by patent owners or holders of New Drug Applications Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Caraco Pharmaceutical Laboratories Ltd. and Sun Pharmaceuticals Industries, Ltd. Prospective legislation establishing a generic drug user fee program Prospective legislation establishing a biosimilar user fee program Establishment of a federal track and trace system for pharmaceuticals The use of Risk Evaluation Mitigation Strategies (REMS) programs by brand drug companies to delay generic competition International Nonproprietary Names for Biosimilars Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   200000 0 0 2012-04-19T14:32:52.267000-04:00
1238268 NOSSAMAN LLP 1eacfb18-0093-4782-8ed9-783a1a334e39 Q1 NOSSAMAN LLP 29846 AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") 2012 first_quarter PHA H.R.905 and S.733, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, H.R.3026 and S.1584, pharmaceutical pedigree anti-counterfeiting legislation. H.R.2245 and S.296, legislation pertaining to drug manufacturing shortages. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-04-19T15:10:55.953000-04:00
1238407 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 8be2179a-a457-4192-b39f-25489385d641 Q1 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 4653 ASSOCIATION OF NATIONAL ADVERTISERS, INC. 2012 first_quarter PHA FDA proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements Comments to FDA on proposal regarding disclosures for online prescription drug advertising FDA draft guidance for direct to consumer prescription drug ads on television Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),Office of Management & Budget (OMB),SENATE   400000 0 0 2012-04-19T15:22:41.347000-04:00
1238578 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION bae0563c-104a-4fe9-96c2-64a0658e4253 Q1 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 first_quarter PHA S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; Sought Congressional support for the FTC investigation of the merger between two major national PBMs; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   450000 0 0 2012-04-19T15:29:35.553000-04:00
1239041 PODESTA GROUP, INC. 3fe24a08-4808-4735-be46-01bcbc054770 Q1 PODESTA GROUP, INC. 31680 MILLENNIUM PHARMACEUTICALS INC 2012 first_quarter PHA Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-19T16:00:14.237000-04:00
1239517 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 1af7044b-fcfc-490c-bd42-6fe3de4f53e1 Q1 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 GENENTECH 2012 first_quarter PHA Monitor Drug Safety and pedigree legislation. Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-19T16:36:27.703000-04:00
1239588 ARNOLD & PORTER KAYE SCHOLER LLP 2949561a-ea17-42cf-a2e2-c1efb7b40b8b Q1 ARNOLD & PORTER KAYE SCHOLER LLP 4301 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS 2012 first_quarter PHA Issues related to the regulation of the practice of pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-04-19T16:41:01.220000-04:00
1239673 RYAN MACKINNON VASAPOLI AND BERZOK, LLP fa0133cf-fb48-4aaf-b3dd-387fcbcf0f9d Q1 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 NOVO NORDISK 2012 first_quarter PHA P.L. 111-148- Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152- The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-04-19T16:46:32.237000-04:00
1239704 BUCHANAN INGERSOLL & ROONEY PC 4f2c336b-d5b8-4a13-b5c2-b81ba359ff6c Q1 BUCHANAN INGERSOLL & ROONEY PC 55291 GENERIC ANIMAL DRUG ALLIANCE 2012 first_quarter PHA Legislative issues relating to United States Food & Drug Administration. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-19T16:49:51.410000-04:00
1240130 TARPLIN, DOWNS & YOUNG, LLC 66cf120b-228a-4bfa-ba3f-89f5a2105b3d Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 BIOTECHNOLOGY INDUSTRY ORGANIZATION 2012 first_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 80000   0 0 2012-04-19T17:25:44.953000-04:00
1240165 TARPLIN, DOWNS & YOUNG, LLC 64e3e97b-b54d-4846-ac1f-9a64e6d1d173 Q1 TARPLIN, DOWNS & YOUNG, LLC 304736 PHRMA 2012 first_quarter PHA **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act ***, no specific bill(s), prescription drug importation, import safety, Prescription Drug User Fee Act and associated policies Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 70000   0 0 2012-04-19T17:29:57.017000-04:00
1240271 C2 GROUP, LLC 75bab424-2202-4433-9039-1450730b184c Q1 C2 GROUP, LLC 66693 AMERICAS HEALTH INSURANCE PLANS (AHIP) 2012 first_quarter PHA H.R. 3988, Generic Drug and Biosimilar User Fee Act (Murphy/Pitts/Waxman) - FDA user fee programs. S. 2193, Ensuring Safe Medical Devices for Patients (Merkley) - FDA oversight of medical devices. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-19T17:39:22.257000-04:00
1240309 GEPHARDT GROUP GOVERNMENT AFFAIRS fd3354ee-a3b9-4c95-92e9-cf13441c89db Q1 GEPHARDT GROUP GOVERNMENT AFFAIRS 315717 HEALIANCE PHARMACEUTICALS 2012 first_quarter PHA innovative diabetes treatment HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-19T17:42:58.710000-04:00
1240345 EMPIRE CONSULTING GROUP 6a159745-801c-4032-a168-f8dcd87ca12b Q1 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2012 first_quarter PHA H.R. 3995, Protecting Consumer Access to Generic Drugs Act; The Prescription Drug User Fee Act ("PDUFA V"); Prescription Drug Abuse; H.R. 452, Medicare Decisions Accountability Act (repealing provisions of healthcare law relating to the Independent Payment Advisory Board/IPAB); S.1002/H.R. 4223, Safe Doses Act; and Biologics Price Competition Act implementation; HOUSE OF REPRESENTATIVES 30000   0 0 2012-04-19T17:46:13.663000-04:00
1240582 C2 GROUP, LLC 24fcf0e2-f29b-4f44-bf3c-97b9197383ea Q1 C2 GROUP, LLC 66693 PERRIGO INC 2012 first_quarter PHA OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-19T18:14:07.643000-04:00
1240754 BLUESTONE STRATEGIES, LLC cb8dfe19-f911-48b3-8a67-186cca41eb1c Q1 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2012 first_quarter PHA Pharmacy Act; Drug Reimportation;Generic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-19T18:43:46.780000-04:00
1240761 DENTONS US LLP 3a354d52-f2f7-4de6-9615-4d5e84c6d2ea Q1 DENTONS US LLP 36105 AMERISOURCEBERGEN 2012 first_quarter PHA H.R. 1483, H.R. 3026, & S. 1584 - Pharmaceutical pedigree anti-counterfeiting; H.R. 2245, S. 296. - drug shortages HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-04-19T18:45:22.123000-04:00
1240970 KAISER FOUNDATION HEALTH PLAN INC. caef8063-2c13-4eb6-acee-a0bb3f404257 Q1 KAISER FOUNDATION HEALTH PLAN INC. 21027 KAISER FOUNDATION HEALTH PLAN INC 2012 first_quarter PHA HR 4095 - Online Pharmacy Safety Act: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet pharmacies. Sponsor: Cassidy (R-LA) Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   190000 0 0 2012-04-19T19:55:52.820000-04:00
1241006 PODESTA GROUP, INC. 515e56d6-d2b9-4101-aeb4-7357e450ea90 Q1 PODESTA GROUP, INC. 31680 BRISTOL-MYERS SQUIBB 2012 first_quarter PHA Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-04-19T20:08:09.230000-04:00
1241036 PODESTA GROUP, INC. d013a39e-93ab-4d11-b2ec-aedb2f63cc0c Q1 PODESTA GROUP, INC. 31680 GENZYME 2012 first_quarter PHA Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Product exclusivity issues. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-04-19T20:17:22.563000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1360.831ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API